Prostate tumor-initiating cells: A new target for telomerase inhibition therapy?
Authors:
- 2 March 2009
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1792 (4) , 289-296
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating CellsCancer Research, 2008
- Limitations of the cancer stem cell theoryCytotechnology, 2008
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- Targeting telomerase for cancer therapeuticsBritish Journal of Cancer, 2008
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancerOncogene, 2007
- High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activityAnnals of Oncology, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Telomeres shorten during ageing of human fibroblastsNature, 1990